Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
- 1 November 2004
- journal article
- review article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 37 (9), 1317-1323
- https://doi.org/10.1016/j.freeradbiomed.2004.07.034
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6Life Sciences, 2003
- Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controlsEuropean Journal of Clinical Investigation, 2002
- Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 CellsAmyloid, 2002
- Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR studyAtherosclerosis, 2001
- Effect of Gemfibrozil on HDL-Associated Serum Paraoxonase Activity and Lipoprotein Profile in Patients with HyperlipidaemiaClinical Drug Investigation, 2000
- Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in RabbitsBiochemical and Biophysical Research Communications, 2000
- Low paraoxonase activity in type II diabetes mellitus complicated by retinopathyClinical Science, 2000
- Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipientsKidney International, 1999
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- Paraoxonase-2 Gene (PON2) G148 Variant Associated with Elevated Fasting Plasma Glucose in Noninsulin-Dependent Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1997